ABCG2 and neoplasm: Tumor cells employ a wide range of mechanisms to develop chemoresistance and evade drug-induced cytotoxicity, including increased drug efflux mediated by ATP-binding cassette (ABC) transporters, reduced intracellular drug uptake, alterations in drug metabolism, inhibition of apoptosis, and activation of pro-survival signaling pathways [21,25,26,27].